Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

Aging people with autism more likely to have Parkinson's disease symptoms (opens in a new tab)

medicalxpress.com · 2026-10-28

Short answerEvidenceSource

Short answer

Mixed

Mixed.

One claim goes further than the study. One other point was not covered by the paper.

  • 4 supported
  • 1 overstated
  • 1 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

One claim overstates the study. Four of six check out. One claim the study doesn't address.

  • 4 supported
  • 1 overstated
  • 1 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

6 claims in this story

Showing all 6 claimsChoose a verdict to focus the list.

Claim 1 of 6OverstatedEven after controlling for prescribed medications, adults with autism still showed an elevated risk of Parkinson's disease symptoms.View evidenceHide evidence

Why this verdict

The abstract supports a narrower point: prevalence elevation persisted after excluding people prescribed antipsychotic medications. The story's wording overstates this as 'controlling for prescribed medications' generally and as elevated 'risk' of symptoms, whereas the cited sensitivity analysis was an exclusion analysis for antipsychotic users and is reported for prevalence.

1

Study evidence

Prevalence of PD-related diagnoses was higher in autism-related groups compared with controls.Autism only: 3.83% vs Control: 1.57%

“Prevalence and incidence were examined among 56,970,786 45+ year old persons across four groups (autism only, ID only, autism + ID, and control sample) utilizing U.S.-based, individually linked Medicaid and Medicare health care claims data from 2017 to 2019.”
Claim 2 of 6Not coveredResearchers said more research is needed to determine the age at which Parkinson's symptoms begin to emerge among autistic people and what factors might predict their development.View evidenceHide evidence

Why this verdict

The abstract-level profile includes broad interpretive implications but does not report this specific future-research statement about age of emergence or predictors. It may appear outside the abstract, but it is not verifiable from the supplied abstract-depth profile.

1

Study evidence

Authors assert that the elevated co-occurrence of autism and parkinsonism among older adults has significant scientific, clinical, and service-system implications.

“Overall, elevated co-occurrence of autism and parkinsonism has significant scientific, clinical, and service-system implications.”
Claim 3 of 6SupportedOlder people with autism are more likely to develop symptoms of Parkinson's disease, according to a new study.View evidenceHide evidence

Why this verdict

The abstract-level profile reports age-standardized incidence/risk of newly documented co-occurring parkinsonism that was higher in autism groups than controls. The headline wording is somewhat simplified—paper evidence is claims-defined parkinsonism/PD-related diagnoses, not direct clinical confirmation of Parkinson's disease symptoms—but the associational direction is supported.

1

Study evidence

Age-standardized incidence or risk of newly documented co-occurring parkinsonism was highest in the autism+ID group, followed by autism only, then ID only; all three groups far outpaced the control sample.

“Whether examining broader or narrower (excluding secondary) parkinsonism, the age-standardized incidence or risk of newly documented co-occurring parkinsonism was highest in those with autism + ID, followed by those with autism only and those with ID only, all of which far outpaced control sample findings.”
Claim 4 of 6SupportedAbout 3.8% of people 45 and older with autism had tremors and movement problems linked to Parkinson's disease, compared with under 1.6% of people without either autism or intellectual disability.View evidenceHide evidence

As stated3.8% vs under 1.6%

Why this verdict

The profile reports prevalence of co-occurring PD-related diagnoses of 3.83% in the autism-only group versus 1.57% in controls, matching the story's 'about 3.8%' and 'under 1.6%' framing.

1

Study evidence

Prevalence of PD-related diagnoses was higher in autism-related groups compared with controls.Autism only: 3.83% vs Control: 1.57%

“Prevalence and incidence were examined among 56,970,786 45+ year old persons across four groups (autism only, ID only, autism + ID, and control sample) utilizing U.S.-based, individually linked Medicaid and Medicare health care claims data from 2017 to 2019.”
Claim 5 of 6SupportedThe findings were based on analysis of nearly 57 million Americans age 45 and older who filed Medicare or Medicaid claims from 2017 to 2019.View evidenceHide evidence

As statednearly 57 million Americans

Why this verdict

The profile states that prevalence and incidence were examined among 56,970,786 people aged 45+ using individually linked U.S. Medicaid and Medicare claims from 2017 to 2019.

1

Study evidence

Prevalence of PD-related diagnoses was higher in autism-related groups compared with controls.Autism only: 3.83% vs Control: 1.57%

“Prevalence and incidence were examined among 56,970,786 45+ year old persons across four groups (autism only, ID only, autism + ID, and control sample) utilizing U.S.-based, individually linked Medicaid and Medicare health care claims data from 2017 to 2019.”
2

Study evidence

Age-standardized incidence or risk of newly documented co-occurring parkinsonism was highest in the autism+ID group, followed by autism only, then ID only; all three groups far outpaced the control sample.

“Whether examining broader or narrower (excluding secondary) parkinsonism, the age-standardized incidence or risk of newly documented co-occurring parkinsonism was highest in those with autism + ID, followed by those with autism only and those with ID only, all of which far outpaced control sample findings.”
Claim 6 of 6SupportedThe study also found increased rates of Parkinson's symptoms among people with intellectual disabilities and those with both autism and intellectual disability.View evidenceHide evidence

As stated4.3% and nearly 4.9%

Why this verdict

The profile reports elevated prevalence in the ID-only group and autism+ID group, with values of 4.32% and 4.86% versus 1.57% in controls. It also reports elevated incidence/risk for these groups relative to controls.

1

Study evidence

Prevalence of PD-related diagnoses was higher in autism-related groups compared with controls.Autism only: 3.83% vs Control: 1.57%

“Prevalence and incidence were examined among 56,970,786 45+ year old persons across four groups (autism only, ID only, autism + ID, and control sample) utilizing U.S.-based, individually linked Medicaid and Medicare health care claims data from 2017 to 2019.”
2

Study evidence

Age-standardized incidence or risk of newly documented co-occurring parkinsonism was highest in the autism+ID group, followed by autism only, then ID only; all three groups far outpaced the control sample.

“Whether examining broader or narrower (excluding secondary) parkinsonism, the age-standardized incidence or risk of newly documented co-occurring parkinsonism was highest in those with autism + ID, followed by those with autism only and those with ID only, all of which far outpaced control sample findings.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • The incidence/risk pattern held under broader and narrower parkinsonism definitions, including narrower definitions excluding secondary parkinsonism.

    The story does not mention the broader-versus-narrower outcome definition analysis or the exclusion of secondary parkinsonism.

    From Retrospective administrative claims cohort / incidence estimation

  • Key limitation: at abstract depth, the profile does not report confidence intervals, p-values, or adjusted effect estimates for potential confounders.

    The story does not mention the absence of reported adjusted effect estimates or statistical uncertainty in the abstract-level evidence, which matters when interpreting unqualified 'risk' language.

    From Retrospective claims-based cross-sectional prevalence comparison

6 things the story did carry across
  • Large retrospective U.S. Medicaid/Medicare claims analysis of adults aged 45+ from 2017–2019, with N = 56,970,786.
  • Prevalence of PD-related diagnoses/parkinsonism was higher in autism-only, ID-only, and autism+ID groups than controls, with reported percentages of 3.83%, 4.32%, 4.86%, and 1.57%.
  • Age-standardized incidence/risk of newly documented parkinsonism was higher in autism+ID, autism-only, and ID-only groups than controls.
  • Sensitivity analysis found prevalence elevation persisted after excluding individuals prescribed antipsychotic medications.
  • Key limitation: outcomes and group classifications were based on claims-defined diagnoses and pharmacy claims rather than direct clinical examination, creating possible misclassification.
  • Authors interpret the elevated co-occurrence of autism and parkinsonism as having scientific, clinical, and service-system implications.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

3

Evidence read

study summary

Lead result

secondary data

1Lead resultsecondary dataEstimate and compare age-standardized incidence/risk of newly documented parkinsonism over 2017–2019 across the same four groups, using broader vs narrower definitions (excluding secondary parkinsonism).Retrospective administrative claims cohort / incidence estimationExpand

In plain English

Retrospective claims-based incidence analysis (2017–2019) estimating age-standardized incidence/risk of newly documented parkinsonism among adults aged 45+ across four groups (autism only, ID only, autism+ID, control). Using linked U.S. Medicaid and Medicare claims, the age-standardized incidence/risk was highest in autism+ID, followed by autism only, then ID only; all three groups had substantially higher incidence/risk than the control sample. Results were consistent when using broader versus narrower definitions that exclude secondary parkinsonism.

Key findings

  • Age-standardized incidence or risk of newly documented co-occurring parkinsonism was highest in the autism+ID group, followed by autism only, then ID only; all three groups far outpaced the control sample.
“Whether examining broader or narrower (excluding secondary) parkinsonism, the age-standardized incidence or risk of newly documented co-occurring parkinsonism was highest in those with autism + ID, followed by those with autism only and those with ID only, all of which far outpaced control sample findings.”
2secondary dataEstimate and compare the prevalence of PD-related diagnoses/parkinsonism among adults aged 45+ across four groups (autism only, ID only, autism+ID, and controls) using linked US Medicaid+Medicare claims, including a sensitivity analysis excluding those prescribed antipsychotics.Retrospective claims-based cross-sectional prevalence comparisonExpand

In plain English

Retrospective, claims-based cross-sectional comparison of prevalence of PD-related diagnoses (parkinsonism) among adults aged 45+ classified into four groups (autism only, ID only, autism+ID, control) using individually linked U.S. Medicaid and Medicare administrative claims from 2017–2019 (N = 56,970,786). Reported group prevalence: control 1.57%; autism only 3.83%; ID only 4.32%; autism + ID 4.86%. The higher prevalence in autism-related groups persisted in a sensitivity analysis excluding individuals prescribed antipsychotic medications.

Key findings

  • Prevalence of PD-related diagnoses was higher in autism-related groups compared with controls.Autism only: 3.83% vs Control: 1.57%
  • ID only and autism + ID groups also showed elevated prevalence relative to controls.ID only: 4.32%; Autism + ID: 4.86% (vs Control: 1.57%)
“Prevalence and incidence were examined among 56,970,786 45+ year old persons across four groups (autism only, ID only, autism + ID, and control sample) utilizing U.S.-based, individually linked Medicaid and Medicare health care claims data from 2017 to 2019.”
What this piece can’t prove
  • Reliance on claims-defined diagnoses (ICD codes and pharmacy claims) may limit clinical detail and could involve misclassification; the abstract does not report validation of phenotype definitions.
  • Abstract does not report confidence intervals, p-values, or effect estimates adjusted for potential confounders (information not available in abstract).

1 further detail could not be confirmed from the summary.

3otherFrame scientific/clinical/service-system implications of elevated autism–parkinsonism co-occurrence for older adults.Narrative interpretation/implications discussionExpand

In plain English

The authors interpret their observed elevated prevalence and incidence of co-occurring parkinsonism in older autistic adults (with and without intellectual disability) as having "significant scientific, clinical, and service-system implications," stating this in both the Abstract and Lay Abstract. This statement is presented as an interpretive framing rather than as a separate empirical analysis in the paper.

Key findings

  • Authors assert that the elevated co-occurrence of autism and parkinsonism among older adults has significant scientific, clinical, and service-system implications.
“Overall, elevated co-occurrence of autism and parkinsonism has significant scientific, clinical, and service-system implications.”
What this piece can’t prove
  • Summary is based on abstract text only; full text may contain further elaboration not captured here.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

Parkinsonism Co-occurrence Among Older Autistic Adults, Adults With Intellectual Disability, and a Control Sample of Adults in National Health Care Claims Data

Autism : the international journal of research and practice · 2026

Deep dive in Tessa (opens in a new tab)Source record (opens in a new tab)

Why this one

Near certain

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Crossref · 34 candidate papers

Selected

Parkinsonism Co-occurrence Among Older Autistic Adults, Adults With Intellectual Disability, and a Control Sample of Adults in National Health Care Claims Data

Autism : the International Journal of Research and Practice · 2026 · PubMed, Crossref

Tessa (opens in a new tab)Source (opens in a new tab)
Candidate

Prevalence of epilepsy and young-onset dementia in adults with intellectual disability: Contrasting Down syndrome and autism diagnoses

2026 · Crossref

Source (opens in a new tab)
Candidate

Author response for "Analysis of Multiplexed SERS-based Lateral Flow Assays: Turning Qualitative into Quantitative for Inflammatory Bowel Disease Monitoring"

2026 · Crossref

Source (opens in a new tab)

And 28 more candidates considered.